Natco Pharma Ltd and partner Allergan Plc has settled dispute with US-based drug maker Celgene Corp. in the patent infringement case of the latter’s cancer drug Revlimid.
Tags : NATCO PHARMA CELGENE CORP REVLIMID PATENT
Share :